Biotechnology in South Korea

Geninus Inc

Big Data Analytics in Genomics.

51 to 200 staff

Lsk Global Ps

LSK Global Pharma Services Co, Ltd.(LSK Global PS) is a leading clinical trial-conducting Contract Research Organization (CRO) in South Korea, with experience in every aspect of Korea's clinical research history."A CRO that Embraces Accountability Grounded in competence and Honesty, CRO." Blog(KR): https://blog.naver.com/lskglobalpsblog

201 to 500 staff

Sartorius Korea Biotech

150 - A joint venture with Sartorius - a German company on a 150 years journey of bioprocessing innovations - and has offered the clients trusted, proven R&D, pre-clinical, fermentation, cell culture, purification, clarification, and filtration solutions, and more. With these solutions built on its robust integrated base technologies, Sartorius enables the biopharmaceutical clients to develop biosimilars like therapeutic antibiotics and biologics like vaccines as safely and promptly, with economic feasibility.#SimplifyProgress

201 to 500 staff

Inocras Inc

Inocras is a bioinformatics-led company redefining precision health through whole genome data and proprietary analytics. Our oncology and rare disease platforms integrate comprehensive whole genome data with advanced automation to deliver curated and actionable insights at scale. These capabilities deliver curated, actionable insights that accelerate discovery and diagnostics to improve patient care, bringing a real-world impact. We operate a CLIA/CAP-certified laboratory and partners with leading hospitals, pharmaceutical companies, and research institutions worldwide.

11 to 50 staff

Wells Bio

WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. In this day and age, where the importance of early diagnosis and treatment have been on the rise due to the aging population and globalization of illnesses, WELLS BIO pursues to be the world’s life-caring companion to all mankind.

51 to 200 staff

Koreabio

KoreaBIO, a leading organization in the bioindustry encompassing pharmaceuticals, medical devices, environmental technology, biotechnology, and more, supports the business endeavours of over 600 member companies of various sizes across all sectors of the bioindustry, including red, white, and green. Its mission is to vitalize the Korean bio-industry ecosystem.

11 to 50 staff

Advanced Protein Technologies Corp

Advanced Protein Technologies Corp.(APTech) is a biotechnology company whose business goal is process development and manufacturing products related to biopharmaceutical industry. APTech has a lot of experiences to develop process for pharmaceutical recombinant protein using our platform technology called ADpure System™ since its founding in 2001. We has also produced various kinds of Active Pharmaceutical Ingredients as well as protein materials in pharmaceutical process and other biotechnology. Based on that, APTech has participated actively in both domestic and international business fields. APTech is exerting all possible efforts to materialize its core technology of manufacturing high quality protein with high productivity, which has been steadily demanding from the areas of medicine, food and cosmetic industry.

11 to 50 staff

Medimabbio

MediMabBio is a ground-breaking biotherapeutic company focusing on the generation of novel immunotherapies for the treatment of cancer. Our discovery platform uses advances in systems biology combined with sophisticated immunological solutions to identify significantly improved first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumors. The company has developed a pipeline of highly promising novel drugs that aims to overcome the current limitations of cancer immunotherapy. For this purpose, MediMabBio has established collaborations with core partners of academic, R&D institutions and clinical groups in US, UK, Germany, China and Korea.

11 to 50 staff

Caregen Co. Ltd

Caregen, a global leader in peptide research and development, is a global biotechnology company that has commercialized the unlimited expandability of its patented peptides as many innovative products since its establishment in 2001. Over 600 different functional peptides developed by Caregen for the past 19 years have opened new paradigm in the field of biotechnology by expanding its applications to cosmeceutical, Class medical devices, food supplement, and pharmaceuticals. We are striving to dramatically improve human life and health providing total health care solution through the development, production, and supply of various peptides. Our innovative peptide-based products provide solutions to many people around the world who are pursuing health and beauty with our unique skin delivery technology that maximize the efficacy and effectiveness of products Global leader in Peptide Research and development: Peptide-based products developed by Caregen provide total health care solutions across all areas of the anti-aging industry. By combining unique skin delivery technology, Caregen provides a variety of safe and highly effective cosmeceuticals and medical device products to 130 countries around the world. Caregen’s research goes beyond biomimetic peptide research and maximize the efficacy of biomimetic peptides with a new approach to hybrid peptides. We are expanding these hybrid peptides into a pharmaceutical product with optimal efficacy and safety Innovative R&D: One of the most important features that can define Caregen’s product development capabilities is a product with a variety of functions that are safe and effective for maximum use all based on our various patented peptides. In particular, PTx, which has the world’s first Botulinum Toxin Type C mechanism, provides innovative solutions to many people around the world as its application extending to management of hyperhidrosis, pain, and skin diseases by topical use.

201 to 500 staff

Genuv

Founded in 2016 in South Korea, Genuv() is a clinical-stage biopharma that specializes in discovering and developing innovative therapeutics based on own platform technologies for drug discovery. GENUV is dedicated to the discovery and development of life-transforming therapeutics for patients with debilitating diseases. To do this, we passionately endeavor to advance our own platform technologies and capitalize on our strengths in multi-disciplinary collaborations with external partners. Our current research and development focus is on a) small molecule drugs to treat neurodegenerative diseases through neurogenesis and neural homeostasis and b) antibody drugs for immuno-oncology treatment.

11 to 50 staff

Kangstem Biotech Co., Ltd

Kangstem Biotech was established to develop stem cell therapeutic products for rare and incurable diseases. Our Business [Stem Cell Therapy] Kangstem Biotech has developed the technology to isolate the non hematological system stem cell with multi conversion and high purity from the cord blood and to culture large quantity; and has developed the Furestem® for the stem cell therapy to cure the incurable diseases.(Atopic Dermatitis, Rheumatoid Arthritis, Osteoarthritis)[Stem Cell Conditioned Media] USC-CM (Umbilical cord blood-derived Stem Cell Conditioned Media) is obtained from our patented stem cell culture process. It was proved that it contains plenty of growth factors secreted by differentiating stem cells.[Stem Cell Culture Media] The stem cell conditioned medium (KSB-3 Complete Medium® Kit) of Kangstem Biotech is a medium for culturing the human mesenchymal stem cell, which can enhance the proliferation of stem cells in a state of non conversion and provide with the high proliferation ability and uniform cell state at culturing.[Cell Freezing and Thawing Platform] CryoSupport is a platform for Cellfreezing and Thawing [CDMO] we promise to do our best to support your project as a "Super Supporter"-Contract Manufacturing Organization(CMO)-Contract Development Organization(CDO)[Health & Beauty(H&B) Business] GD11 is a cell bio-derma cosmetic brand that embodies real visual effects on the skin with international patented technology secured through cord blood stem cell research since 1994 and a proven ingredient in Human Cord Blood Cell Conditioned Media, USC 1994®. for more information visit our website

51 to 200 staff

Microbiotix Co., Ltd

Microbiota banking FMT 19.

11 to 50 staff

Hs Biosystems

We are based on connection and development for BIT to develop the Bio-infra instrument and reagents for using molecular diagnostics. Through the C&D technologies, we will lead the personnel optimized clinical diagnostic market by exact, convenient and competitable product. We must contribute for human well-being as a technology based bio-company which provides the best service and quality of goods.

1 to 10 staff

Noblekinmat Ltd

An impact Development company with the mandate of ‘leading a generation of impact, prosperity and sustainability’ among Africans in the area of Bioinformatics, Data Science, Health, Education, Media and Publicity. NOBLEKINMAT Ltd. is dedicated to leading the next frontier of Africa’s development in all spheres of the continents’ transformational plan through the digitalization and democratization of knowledge and skilled manpower. We are dedicated to building a strong workforce for companies, institutions and government agencies working towards that collective goal of creating a future for Africa and beyond. The company was founded officially in 2022 to create IMPACT, PROSPERITY and a SUSTAINABLE development through empowering, engaging and equipping people at all age grade and levels through the company’s platforms. At the end of the year 2022, we aim to raise and train a more than a million individual in every aspect of our Company’s mandate across Africa and beyond. We would fulfil this mandate by identifying opportunities at each level of societal strata through outreach to community leaders and organizations, and networking with the right donors/investors to achieve the desired goal.

11 to 50 staff

Kogenebiotech

KogeneBiotech is a leading company in the in-vitro diagnostics industry and has developed the 1st SARS-CoV-2 Real-time PCR Kit in South Korea, January 2020. We are a representative with a significant contribution in the early diagnosis and prevention of the spread of COVID-19 successfully. KogeneBiotech – the first mover of the Real-time PCR assay – has developed more than PCR Kits. As a result, we have established an extensive product portfolio in emerging diseases, clinical diagnostics, food safety, animal diseases, and pathogens. We strive to ensure and improve public healthcare while maintaining continuous cooperation with the government authorities, the national research institutes, the great hospitals, and medical centers.

51 to 200 staff

Nobo Medicine

We are a clinical-stage biotech company pioneering novel therapies for hematologic cancers and diseases linked to clonal hematopoiesis (CH)—a key driver of immune aging. Our lead program, granted Orphan Drug Designation by the Korean Ministry of Food and Drug Safety, is currently undergoing a pivotal clinical trial in Korea. We are driven by a sense of urgency and purpose to translate cutting-edge science into transformative treatments—bringing new hope to patients with limited options. For more information, please visit our website- Official Website: https://en.nobomedicine.com/

11 to 50 staff

Gradiant Bioconvergence

Gradiant Bioconvergence (GBCC) is a pioneer in the development of patient-derived cancer organoids (PDOs) on a global scale. We have established Asia’s largest PDO repository, comprising over 800 models from patients with lung, gastric, colorectal, pancreatic, and ovarian cancers, all characterized using next-generation sequencing. In parallel, we are advancing co-culture systems that integrate autologous immune cells and cancer-associated fibroblasts with our PDOs. Leveraging our comprehensive genomic, transcriptomic and drug response datasets, we are identifying and validating novel drug-resistant oncology targets through our AI-driven discovery engine and CRISPR-enabled PDO platform. Beyond oncology, GBCC is also developing brain organoids from human iPSCs to support drug evaluation, disease modeling and regenerative medicine applications.

11 to 50 staff

Imnewrun

IMNEWRUN creates breakthrough solutions for patients with brain diseases. Our focus includes novel, next-generation blood-brain barrier-penetrating antibodies. IMNEWRUN is a learning platform designed to spark innovation, where students, faculty, and industry experts interact closely to create exponential learning opportunities. We bring synergy to accelerate new scientific discoveries and to develop next-generation treatment modalities We are a team of passionate scientists and professionals who are committed to serving humanity through biotechnology. We are enthusiastic explorers in understanding fundamental science and creating a culture that inspires lives of many. We invite you to learn more about IMNEWRUN and how we are working to make a difference in the world.

11 to 50 staff

Inertia Inc

INERTIA is a Korean female engineer-based startup, founded at KAIST. We aim to be a pioneer in illuminating and resolving the discomfort of women with empathy and technology.

1 to 10 staff

Sp2tx

SP2 Therapeutics is redefining peptide synthesis, addressing core biopharmaceutical production challenges. Our patent-protected FLOWSMART system combines Nobel-prize winning solid phase peptide synthesis with AI-guided, resin-based flow chemistry, achieving massive cost savings and scalability. SP2 Therapeutics is a spinout from Seoul National University's renowned Institute of Molecular Biology and Genetics. Our core team’s expertise spans diverse domains such as resin-based chemistry, bioinformatics, engineering, and machine learning. Our FLOWSMART synthesis platform can greatly accelerate your peptide drug development efforts.

1 to 10 staff

Spl Life Sciences

SPL Life Sciences Co, Ltd. is a leading manufacturer/ exporter in scientific plastic lab-ware of Korea. Since established in 1987, we are dedicated to manufacture high quality plastic lab-ware, consistent to the finest standards in the industries. With a team of enthusiastic professionals continuously engaging in research, development and quality control, our products fully comply with the international regulatory requirements. For over three decades in the industry, we have gained enormous amount of knowledge and experiences. Our highly qualified and experienced personnel strive for their best to produce high quality products at competitive prices. Along with the dominant position in the domestic market, we have excelled in the international trade with customers in the United States, most countries in Europe and Asia. We are rapidly gaining international reputation by promptly developing most advanced products used in life science field. We, SPL Life Sciences, are committed to meet the needs of the customers on providing up-to-date life science technology. With active investments in the Research & Development, we now offer more innovative solutions in a wide range of life science applications.

51 to 200 staff

Cell Biotech Co., Ltd

Cell Biotech is a group of more than 300 microorganism specialists who focus their research entirely on probiotics only. Based on our world-patented dual coating technology, we have created a probiotic-specialized "One Stop Solution" to develop the best probiotic products with the aim of improving the intestinal health of people around the world. Cell Biotech is Korea’s leading probiotics company exporting to forty countries around the world and managing five brand businesses in South Korea, Denmark, France, Poland and Singapore. We have established partnerships with multinational companies and local retailers to distribute our products. With over two decades of probiotics business experience, we have localized our products to meet the needs of diverse cultures, ethnicities, regions, and climates.

201 to 500 staff

Seoulin Bioscience

SeouLin Bioscience'(SLB) is the total solutions provider in life sciences & healthcare since 1984. SLB aims to grow as a global leading bio company that provides differentiated service with the mission of customer success. We hold 15 local agencies that are being trained by SLB in every month to strengthen professionalism and over customer database in genomics, proteomics, cell biology, bioinformatics, and bioprocess. Based on our bio-industry sales experience, we have provided eco-friendly Hypochlorous acid(HOCl) generator ecoTreeTM to meet the customers' needs for sterilized water. From research laboratories to industrial fields, our new business has expanded to more than one hundred customer sites that requires the sterilization and sanitation.

51 to 200 staff

Therapex Co., Ltd

11 to 50 staff

Cellgentek Co., Ltd

We create the most optimal bioimaging instrument with brilliant ideas.

11 to 50 staff

Atg Lifetech

ATG Lifetech Inc. is a cutting-edge biotechnology company specializing in new drug development and single-cell RNA-seq technology. The company is composed of experts dedicated to advancing scientific research and developing innovative solutions in biotechnology and medicine. ATG Lifetech is renowned for its high-quality oligonucleotide libraries and next-generation sequencing (NGS) technologies, which are essential for various applications, including transcriptome-wide analysis. The company is also actively engaged in Organ-on-a-Chip research, contributing significantly to the study of complex biological systems. ATG Lifetech’s work in this area includes comprehensive data analysis and the development of robust methodologies for low-input samples, such as organoid and Organ-on-a-Chip systems.

11 to 50 staff

Biovit Co., Ltd

As a biotech startup company, BIOVIT aims to create a safer and cleaner world with the use of outstanding biotechnology. BV Peptide Stabilization Platform (PSP) is a technology that utilizes pure bio materials to increase the efficacy and stability of peptides by a large margin. BIOVIT’s PSP technology emphasizes in three things: 1) Safety on human health, selectively killing only pathogens; 2) Outstanding efficiency and stability, and 3) Significant versatility in adhesive properties, making it easy to apply on various fields. BIOVIT, with the use of biotechnology, is giving all their efforts to solve infection issues. Starting with the application of antimicrobial proteins on routine objects and surfaces, then ultimately reaching out as medical product, BIOVIT aims to continue improving their proteins. If you want more information about the PSP technology and BIOVIT products, please visit or send us your inquiries to biovit@biovit.co.kr

1 to 10 staff

Bluecore Company Co., Ltd

Late Runner must be Better. Our new Aesthetic & medical Laser devices (Q-switched Nd:YAG, Er:YAG, CO2, and PICO) are ready. Want you to see what the better is?

11 to 50 staff

Danagreen

DaNAgreen Co, Ltd. is a Seoul-based biotechnology company founded in 2017. Using our patented protein crosslinking technology, we produce scaffolds that allow cells to culture in 3D. Our proprietary Protinet scaffold will be a key component in the production of cultured meat.

11 to 50 staff

Medinno

Medinno Inc. has been striving to develop cell therapeutics for brain diseases for over 15 years to give hope to numerous patients and families suffering from brain diseases.

11 to 50 staff

Alteogen

Alteogen is a leading biopharmaceutical company with a robust pipeline of next-generation biologics featuring enhanced efficacy, enabled by its proprietary platform technologies. Founded in 2008, the company is listed on the KOSDAQ stock exchange (KRX:196170). Alteogen’s most distinguished platform, Hybrozyme™, is a novel human hyaluronidase technology that enhances the absorption of biologic drugs administered via subcutaneous injection. This proprietary hyaluronidase demonstrates improved enzymatic activity and thermal stability compared to existing alternatives. Another key innovation, NexP™ fusion technology, is designed to extend the half-life of therapeutic proteins and peptides in the human body. It is currently applied to the development of long-acting biologics, including human growth hormone, exenatide (for diabetes), and Factor VIIa (for hemophilia). The company’s proprietary antibody-drug conjugate platform, NexMab™ ADC technology, enables targeted cancer therapies with improved efficacy and reduced side effects. Using this platform, Alteogen is developing ADC therapeutics for breast, gastric, and ovarian cancers. With extensive expertise and experience, Alteogen has also established its own high-expression cell lines, efficient upstream and downstream processes, and optimized analytical methods to support the development of monoclonal antibody biosimilars.

51 to 200 staff

Simple Planet

Simple Planet: Leading Sustainable Food Innovation Simple Planet envisions a future where sustainability and innovation converge to protect our planet. As a leading bio-food tech company based in South Korea, we specialize in developing advanced food ingredients through cell culture technology. This pioneering approach not only contributes to reducing carbon emissions but also strengthens food security and biodiversity essential in addressing climate change. Core Technologies: • Expertise in securing critical cell lines and utilizing SCDP (Suspension Cell Differentiation Development Platform). • Developed 13 specialized cell lines for cell-cultured foods from sources including cattle, poultry and fish. • Innovating mass culture processes using SIMPLE Planet SCDP technology to enhance production efficiency. • Achieved cost savings through the development of safe, serum-free edible culture media. 🥩 Key Products: • High-Protein Cell-based Meat Powder: Alternative protein sourced through animal-cell cultivation • Unsaturated Fatty Acids Animal-Fat Paste: cell-based fat with elevated unsaturated fatty acid content. • Customizable raw materials enhancing nutrition and flavor for various food and functional applications."SIMPLE planet.". Core Technologies • SCDP () •, 13 • SCDP • • 🥩 Key Products • ''/ • : • :

11 to 50 staff

Clecell Co.,ltd

CLECELL Co, Ltd. is a bio-platform company established to create a new future in the field of diagnosis and treatment through advances in the fields of tissue engineering and regenerative medicine based on the latest 3D Bioprinting technology. We are promoting the early expansion and commercialization of the field of 3D bioprinter utilization in the field of regenerative medicine through joint research with research institutes, biotechnology companies, and hospitals. Contact us for inquiries.#Artifical skin #Clecell3d #Clecell #TissueEngineering #Healthcare #Bioprinting #MedicalDevice #CellTherapy

11 to 50 staff

Curome Biosciences

CUROME BIOSCIENCES is a biotech company in South Korea. Phase 2 clinical trial for Primary Sclerosing Cholangitis(PSC) is ongoing.

11 to 50 staff

Novelty Nobility Inc

Novelty Nobility Inc. is a private clinical stage biotech company located in Pangyo, South Korea, and Boston, Massachusetts. We are currently focused on the research of novel angiogenesis targets and develop antibody-based therapeutics in ophthalmology and oncology, where angiogenesis plays a key pathogenic role. Novelty Nobility, a unique name for a biotech company, stands for what we pursue – Novel Science, Noble Management. The emblem in the middle of our logo, which shapes a drug, symbolizes our belief that a new drug is born when novel science meets noble management.

11 to 50 staff

Stemlab

StemLab is a Korean biotech company that is developing therapeutic solutions to treat diseases and injuries that have no alternative cures. In particular, it develops cells that can regenerate the central nervous system tissues based on its cell reprogramming technology that transforms somatic cells into stem cells. Stemlab’s cell reprogramming technology takes fully differentiated cells and reprograms them into neural stem cells, allowing them to obtain the stem cells necessary to create stem cell therapies. It thus avoids the ethical issues concernng embryonic stem cell research. Also, its reprogrammed neural stem cells have expansion capability comparable to neural stem cells derived from pluripotent stem cells. And since StemLab obtains somatic cells through urine, harvesting is much less invasive than using cells obtained using other invasive means. StemLab's technology is backed up with 18 patents for original technology related to stem cell treatments and has three patents for application technology, with another five pending. Its initial clinical programs will involve patients with spinal cord injury (SCI) and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).

11 to 50 staff

Contera Pharma

Contera Pharma discovers and develops innovative therapies to improve life for people suffering from neurological disorders.

11 to 50 staff

Mediforum Co., Ltd

11 to 50 staff

Peptron, Inc

Established in 1997, Peptron focuses on platform technology and clinical developments. Referred to as "Cozy-Cure," Peptron's highest priority is promoting and promising the best quality of life for patients with better treatment options, compliance, and price advantage. Peptron members' expertise in drug discovery and research, business development and strategic planning, drug delivery and formulation, GMP production, and Quality Control has helped develop peptide-based platform technology, SmartDepot™. SmartDepot™ brings the initial research process to the final medication development and successful commercialization phase with superior competitiveness. In line with proprietary technologies, we develop sustained-release (SR) medications to extend the release profile of the drug from weekly to monthly. Further, Peptron values global CDMO business. In the last few years, we have successfully formulated working with global companies with our in-depth expertise and resources. Peptron can work with you to achieve formulation development, regulatory approval and commercial manufacturing. Contact us: biz@peptron.co.kr

51 to 200 staff

Selecxine

Selecxine is a biopharmaceutical development company specialized in the field of immunotherapeutics. Selecxine strives to develop immunotherapeutics – a new paradigm of pharmaceuticals– through a specialized antibody development process, using an innovative platform technology of functional antibody screening and development. We endeavor to improve the survival rate and quality of life of cancer patients by developing anti-cancer immunotherapeutics that selectively stimulate the immune cells. These agents act against tumor cells through the regulation of cytokine function, which plays a key role in the enter cell activities. Based on our technology and expertise in the pharmacology and development field, we aim to provide safe and efficient therapeutics and innovative solutions for next-generation pharmaceuticals. CEO, Selecxine Inc. Jun-Young Lee

11 to 50 staff

Legochem Biosciences

LegoChem Biosciences, Inc.(LCB) is a research-based biotechnology company dedicated to the discovery, development, and commercialization of innovative medicines by leveraging our chemistry expertise to make conventional biologics more targeted and potent for the benefit of patients with diseases of highly unmet medical needs. We are advancing sustainable pipelines in therapeutic areas within antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).

51 to 200 staff

Nexel

NEXEL Co, Ltd. spun off from Korea University in 2012 with its proprietary stem cell technology and by the end of 2017 has introducedHEPATOSIGHT-S and CARDIOSIGHT-S to the market These fully functional human cell products can currently be used for a variety of research, including drug screening and toxicity tests. During our research with the stem cell, we were lucky enough to stumble upon a molecule with a significant anti-fibrotic effect. Nexel has carried out various studies to optimize its stability, manufacturability, and efficacy by modifying its structure in collaboration with respected CROs in South Korea. The new drug candidate was named NP-011 and has 4-folds higher anti-fibrotic effect compared to its parent molecule. The primary indication for NP-011 is NASH and Liver Fibrosis, and use in other fibrotic diseases are currently being evaluated. NEXEL's goal for NP-011 is to find a partner with experience and expertise for co-development and file for IND by the end of 2019 with K-FDA. If you have any questions regarding either of NEXEL's human cells or protein therapy, please feel free to contact at support@nexel.co.kr Thank you.

11 to 50 staff

Daewoong Bio Inc

Daewoong Bio Inc. is a biotechnology company based in Hwaseong (Hyangnam), South Korea. Address: 35-9, Jeyakgogdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, South Korea, 18623

51 to 200 staff

St1 Corp. With An Official Brand Of Artipore

We develop, produce and sell biotechnology equipment and biomaterial products based on electrospinning device and bioprinting equipment manufacturing technology, biocompatible nanofiber manufacturing and bioprinting technology. Based on 3D cell culture equipment, we support the growth of various biomaterials industries, from development through clinical trials to commercial manufacturing according to GMP standards. In addition, based on the expertise of leading researchers in the biotechnology industry, it is managed multinationally with the organizational agility of startups. With research of 3D cell culture beyond 2D cell culture, we are making progress in life science. Accumulated technology of utilizing biocompatible material such as PCL(Polycaprolactone), collagens, etc, it enables our teams to develop various biocompatible medical devices, biomaterials. In addition, to expand our research to various fields, ST1 is actively conducting joint research with hospitals, research institutes, and universities.

11 to 50 staff

Doai Inc

We, DoAI is developing AI powered early stage of cancer diagnostic solutions, especially focusing on the early stage of pancreatic cancer diagnosis. We aim to provide affordable and effective health care benefits for everyone as using Nano-Raman & AI technology. Our vision is “Be the leading AI-enabled medical solution provider and accelerator of predictive, preventive, personalized and particularized health practice for patients”

11 to 50 staff

Mecasys

Mecasys Co. Ltd. has been a prominent and honest manufacturer in spectroscopic field for customers' needs, since 2001. Our employees have an ardor and diligence to support and service all needs of customers. Our advanced technologies with timely needs has been the base to create spectroscopic analysis instruments to provide customers as whole system such as highly precise spectrophotometer, better analysis system, on/off software, and solutions. In modern time, we are frustrated from trying to figure out why your endotoxin level are so high even though you've just disinfected, since there are much chemicals in your food, water, contaminated chemicals, and just alike. Becoming more responsible for needs to clean off chemicals, there are much ardor, time, money to have batter system to test, to measure, to analyze and so on. Mecasys gives you the solution to analyze this odds. The experience gained Mecasys in both optical design analysis and computer technology led to the production of spectrophotometric analyzer. Mecasys has been establishing good experience in the design and development of innovative instrumentation for a wide range of applications in Korea as well as overseas. Mecasys Co, Ltd. suggests better analyzing in biochemistry, pharmaceutical, educational, industrial, quality control and research laboratories n with ardor and diligence. If you have further inquiry, please contact us overseas@mecasys.co.kr.

51 to 200 staff

Ahram Biosystems, Inc

Ahram Biosystems, Inc. is a research-oriented biotechnology company that develops and commercializes innovative portable high-speed PCR devices and cell-based assay systems. Ahram Biosystems provides leading-edge scientific products and services in the areas of life science and pharmaceutical research, and healthcare applications. Founded in 2001, Ahram Biosystems holds numerous patents in the area of PCR amplification and cell based assays. Ahram Biosystems has its headquarters in Seoul, Korea and a business office in Silicon Valley, CA, USA.

11 to 50 staff

Antero Engineering

Antero is an Engineering and Consulting Services company that support customers in the Life Sciences field achieve their goals in capital investment and manufacturing by applying lean, holistic and pioneering technical solutions and project engineering principles

11 to 50 staff